Met Life Investment Management, LLC Kezar Life Sciences, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$2.31 - $3.06 $78,900 - $104,517	34,156 New	34,156 $83,000
Q2 2023 Aug 10, 2023	BUY	$2.31 - $3.06 $37,170 - $49,238	16,091 Added 89.07%	34,156 $83,000
Q1 2023 May 09, 2024	BUY	$3.13 - $7.31 $56,543 - $132,055	18,065 New	18,065 $56.5 Million
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $31,381 - $73,290	-10,026 Reduced 35.69%	18,065 $56,000
Q4 2022 Jun 14, 2023	BUY	$6.39 - $8.8 $64,066 - $88,228	10,026 Added 55.5%	28,091 $197,000
Q3 2022 May 10, 2024	BUY	$7.99 - $10.75 $63,536 - $85,484	7,952 Added 39.49%	28,091 $241,000
Q3 2022 Jun 14, 2023	BUY	$7.99 - $10.75 $80,107 - $107,779	10,026 Added 55.5%	28,091 $241,000
Q3 2022 Mar 22, 2023	BUY	$7.99 - $10.75 $63,536 - $85,484	7,952 Added 39.49%	28,091 $241,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $63,536 - $85,484	7,952 Added 39.49%	28,091 $242,000
Q2 2022 Jun 20, 2023	BUY	$4.58 - $17.13 $9,498 - $35,527	2,074 Added 11.48%	20,139 $166,000
Q1 2022 May 10, 2024	BUY	$12.3 - $18.33 $247,709 - $369,147	20,139 New	20,139 $334,000
Q1 2022 Jun 20, 2023	BUY	$12.3 - $18.33 $25,510 - $38,016	2,074 Added 11.48%	20,139 $334,000
Q1 2022 Mar 22, 2023	BUY	$12.3 - $18.33 $88,596 - $132,030	7,203 Added 55.68%	20,139 $334,000
Q1 2022 May 12, 2022	BUY	$12.3 - $18.33 $88,596 - $132,030	7,203 Added 55.68%	20,139 $335,000
Q4 2021 Jun 21, 2023	SELL	$7.44 - $16.72 $38,159 - $85,756	-5,129 Reduced 28.39%	12,936 $216,000
Q3 2021 May 17, 2024	BUY	$4.85 - $9.73 $62,739 - $125,867	12,936 New	12,936 $111,000
Q3 2021 Jun 21, 2023	SELL	$4.85 - $9.73 $24,875 - $49,905	-5,129 Reduced 28.39%	12,936 $111,000
Q3 2021 Mar 22, 2023	BUY	$4.85 - $9.73 $29,070 - $58,321	5,994 Added 86.34%	12,936 $111,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $62,739 - $125,867	12,936 New	12,936 $112,000
Q2 2019 Jul 12, 2023	SELL	$7.09 - $21.9 $78,862 - $243,593	-11,123 Reduced 61.57%	6,942 $53.5 Million
Q2 2019 Aug 14, 2019	SELL	$7.09 - $21.9 $49,218 - $152,029	-6,942 Closed	0 $0
Q1 2019 Jul 13, 2023	SELL	$16.83 - $23.75 $187,200 - $264,171	-11,123 Reduced 61.57%	6,942 $123,000
Q1 2019 Mar 22, 2023	SELL	$16.83 - $23.75 $355,937 - $502,288	-21,149 Reduced 75.29%	6,942 $123,000
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $116,833 - $164,872	6,942 New	6,942 $123,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.2M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$45.4 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$31.9 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.1 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17.4 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$15.9 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $433M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account